𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy

✍ Scribed by Bagri, A.; Berry, L.; Gunter, B.; Singh, M.; Kasman, I.; Damico, L. A.; Xiang, H.; Schmidt, M.; Fuh, G.; Hollister, B.; Rosen, O.; Plowman, G. D.

Book ID
121826672
Publisher
American Association for Cancer Research
Year
2010
Tongue
English
Weight
737 KB
Volume
16
Category
Article
ISSN
1078-0432

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Simple ODE models of tumor growth and an
Simple ODE models of tumor growth and anti-angiogenic or radiation treatment
✍ R.K. Sachs; L.R. Hlatky; P. Hahnfeldt πŸ“‚ Article πŸ“… 2001 πŸ› Elsevier Science 🌐 English βš– 869 KB

Models of tumor growth and treatment based on one or two ordinary differential equations are heavily used in practice because they are simple but can often still capture the essence of complicated interactions. Currently relevant examples of such models are given here: some classic growth equations,

CXCR4 peptide antagonist inhibits primar
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
✍ Saima Hassan; Marguerite Buchanan; Kaushar Jahan; Adriana Aguilar-Mahecha; Louis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 527 KB

## Abstract CXCR4 is a chemokine receptor implicated in the homing of cancer cells to target metastatic organs, which overexpress its ligand, stromal cell‐derived factor (SDF)‐1. To determine the efficacy of targeting CXCR4 on primary tumor growth and metastasis, we used a peptide inhibitor of CXCR